Get an alert when SIGMA PHARMACEUTICALS PLC files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2027-02-28 (in 9mo)

Last filed for 2025-08-31

Confirmation statement due

2026-07-20 (in 2mo)

Last made up 2025-07-06

Watchouts

None on the register

Cash

£1M

+11.6% vs 2024

Net assets

£27M

-13.6% vs 2024

Employees

423

-1.6% vs 2024

Profit before tax

-£5M

-140.8% vs 2024

Name history

Renamed 1 time since incorporation

  1. SIGMA PHARMACEUTICALS PLC 1986-11-19 → present
  2. ROXBURGHE EXPORTS LIMITED 1981-05-15 → 1986-11-19

Accounts

2-year trend · latest reflected 2025-08-31

Metric Trend 2024-08-312025-08-31
Turnover £271,457,000£218,609,000
Operating profit £13,685,000-£3,295,000
Profit before tax £13,361,000-£5,455,000
Net profit £10,232,000-£4,286,000
Cash £1,080,000£1,205,000
Total assets less current liabilities £70,395,000£64,430,000
Net assets £31,482,000£27,195,000
Equity £31,482,000£27,195,000
Average employees 430423
Wages £14,128,000£14,703,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-08-312025-08-31
Operating margin 5.0%-1.5%
Net margin 3.8%-2.0%
Return on capital employed 19.4%-5.1%
Current ratio 2.68x2.64x
Interest cover 7.50x-1.27x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Blick Rothenberg Audit LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors believe that the company has adequate resources to continue in operational existence and meet its liabilities as they fall due for the foreseeable future, being a period of at least twelve months from the date these financial statements were approved. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.”

Group structure

  1. SIGMA PHARMACEUTICALS PLC · parent
    1. Selective Supplies Limited 100% · United Kingdom
    2. OPD Laboratories Limited 100% · United Kingdom
    3. Special Concept Development (UK) Limited 100% · United Kingdom
    4. RX Farma Limited 100% · United Kingdom

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

7 active · 15 resigned

Name Role Appointed Born Nationality
SHAH, Bhavin Manish Secretary 2021-01-05
HAMPTON, Mark Richard Director 2022-07-01 Jun 1964 British
HARIA, Rajesh Shantilal Director 2020-04-21 Dec 1964 British
MOIR, James Marcus Henry Director 2022-04-14 Jan 1965 British
SHAH, Bhavin Manish Director 2011-03-04 Jun 1983 British
SHAH, Hatul Bharat Kumar Director 2011-03-04 Oct 1978 British
SHAH, Rajiv Bharat Kumar Director 2011-03-04 Jan 1985 British
Show 15 resigned officers
Name Role Appointed Resigned
SHAH, Bharat Kumar Secretary 1994-03-02
SHAH, Kamal Hansraj Secretary 1994-03-02 2004-03-10
SHAH, Manish Hansraj Secretary 2004-03-10 2021-01-05
PATEL, Pravesh Director 2020-04-21 2021-07-26
SHAH, Bharat Kumar Hansraj Devraj Director 2020-12-22
SHAH, Divya Kamal Director 1995-03-01 2009-03-15
SHAH, Hansraj Devraj Director 2001-04-02 2015-04-26
SHAH, Jayoti Bharat Director 1995-03-01 2020-04-21
SHAH, Kalpana Manish Director 1995-03-01 2020-04-21
SHAH, Kamal Hansraj Director 2020-12-22
SHAH, Manish Hansraj Director 2020-12-22
SHAH, Nishal Kumar, Dr Director 2016-02-10 2020-04-21
SHAH, Paras Kamal Director 2014-11-12 2025-05-06
SHAH, Sachin Manish Director 2016-02-10 2020-04-21
SHAH, Vinod Jethalal Director 1994-03-02

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Orion Holdings (Uk) Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 200 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2025-08-20 RESOLUTIONS Resolution
  • 2025-08-06 MA Memorandum articles
  • 2025-08-06 MA Memorandum articles
Date Type Category Description
2026-03-31 CH01 officers Change person director company with change date PDF
2026-03-31 CH01 officers Change person director company PDF
2026-03-30 CH01 officers Change person director company with change date PDF
2026-03-30 CH01 officers Change person director company with change date PDF
2026-03-30 CH01 officers Change person director company with change date PDF
2026-02-24 AA accounts Accounts with accounts type full
2025-08-20 RESOLUTIONS resolution Resolution
2025-08-06 MA incorporation Memorandum articles
2025-08-06 MA incorporation Memorandum articles
2025-07-31 MR04 mortgage Mortgage satisfy charge full PDF
2025-07-31 MR01 mortgage Mortgage create with deed with charge number charge creation date PDF
2025-07-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-05-06 TM01 officers Termination director company with name termination date PDF
2025-02-07 AA accounts Accounts with accounts type full
2024-07-25 CS01 confirmation-statement Confirmation statement with updates PDF
2024-02-07 AA accounts Accounts with accounts type group
2023-10-18 PSC05 persons-with-significant-control Change to a person with significant control PDF
2023-07-11 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-05-25 MR04 mortgage Mortgage satisfy charge full
2023-05-25 MR04 mortgage Mortgage satisfy charge full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
13

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-08-31 vs 2024-08-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page